Letting the rich pay for science that interests them is a bad idea—even if they aren’t convicted sex offenders.

Kaoru Sakabe is academic publishing’s version of an in-house detective. In 2017, she and editors at the Journal of Biological Chemistry (JBC) conducted a pilot study looking for image manipulation in accepted papers. When 10% of papers came back with a possible issue, the team was shocked.

Switzerland will soon vote on whether to cancel the agreement on the free movement of persons, thus terminating the well-established Bilateral Agreements with the EU. Only by networking fully with its European neighbors and the world in general, can the high standards the Swiss hold for themselves be maintained.

Schools face rising demands for tuition rebates, increased aid and leaves of absence as students ask if college is becoming "glorified Skype."

Generating new knowledge is a relatively straightforward concept compared with the more unknown territory of getting knowledge to those that might need it.

Universities and those who work there must reimagine spaces, behaviour and processes to promote a sense of belonging for everyone.

Leaked letter to Commission shows major pushback against ERC Scientific Council's doubt over open-access initiative

Pandemic policy must include defining and measuring what we mean by mild infection.

Mike Schäfer & Jing Zeng on the particularities of conspiracy theories on COVID-19, how to face them, and what role science communicators play while doing so.

COVID-19 has turned all journalists into health journalists. Epidemiology training can help journalists improve their reporting, and help fight misinformation.

Hong Kong Principles seek to replace 'publish or perish' culture.

Don't worry, a little Bayesian analysis won't hurt you.

Sampling simulated data can reveal common ways in which our cognitive biases mislead us.

Under the pressure of a global health crisis, the argument for open access has sunk in. Is this the catalyst that breaks up the bonds of an old publishing model once and for all?

The COVID pandemic may leave us stuck between a growing consensus that open science is the superior way to drive progress and an inability to invest what may be needed to make it happen.

Scientists need to show us the data. And that's exactly what they're working on.

On the risks of skipping Phase 3 vaccine trials.

The pandemic is sabotaging the careers of researchers from under-represented groups, but institutions can help to staunch the outflow.

The proposed October coronavirus vaccine deadline intersects nicely with President Trump’s need to curb the virus before the presidential election in November.

Tens of millions of Americans are working from home and many will never go back; employers scramble to figure out what tools they'll need to stay productive.

Research is for the experts. Listen to them instead.

Transmission through aerosols matters - and probably a lot more than we've been able to prove yet.

As a Black woman who is the chair of a university science department, people have questioned my right to exist at every stage.

It's never been a more important time for colleges to encourage STEM experts to participate in the policy-making arena.

By calling its new policy a "Rights Retention Strategy," cOAlition S is engaging in doublespeak. This strategy actually does exactly the opposite of what it claims.

The main issues any modernisation of the scholarly infrastructure today needs to address are reliability, affordability and functionality.

Research moves fast. Policies and practices change quickly. Information flows rapidly. Google and other dynamic online services move with blistering speed. Libraries have a hard time keeping up. Ph…

One of the many unique features of this time is the level of public discussion about research and the role of experts in policy making. 

Today, remove the altmetrics.com badges from their landing pages-and we couldn't be more energized by their commitment to open infrastruct…